Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

SMB01361

Sigma-Aldrich

Phosphoramide mustard cyclohexylamine

≥95% (HPLC)

Synonyme(s) :

N,N-Bis(2-Chloroethyl)phosphorodiamidic acid, cyclohexylamine, Friedman acid, cyclohexylamine, PAM cyclohexylamine, PM cyclohexylamine, PMC, Phosphamide mustard, Cyclohexylamine, Phosphorodiamidic mustard, Cyclohexylamine

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme


About This Item

Formule linéaire :
C4H11Cl2N2O2P · C6H13N
Numéro CAS:
Numéro MDL:
Code UNSPSC :
12352209
Nomenclature NACRES :
NA.22

Niveau de qualité

Pureté

≥95% (HPLC)

Forme

solid

Température de stockage

-10 to -25°C

Chaîne SMILES 

ClCCN(P(N)(O)=O)CCCl.NC1CCCCC1

InChI

1S/C6H13N.C4H11Cl2N2O2P/c7-6-4-2-1-3-5-6;5-1-3-8(4-2-6)11(7,9)10/h6H,1-5,7H2;1-4H2,(H3,7,9,10)

Clé InChI

BGTIPRUDEMNRIP-UHFFFAOYSA-N

Description générale

Phosphoramide mustard cyclohexanamine, a potent cytotoxic metabolite derived from the anticancer drug cyclophosphamide, acts as a remarkable alkylating agent. It is generated from cyclophosphamide through the ring-opened tautomer of the cytochrome P450 (CYP) isoform-formed intermediate 4-hydroxycyclophosphamide. This metabolite exerts its cytotoxic effects by inducing DNA crosslinking, guanine alkylation, and the formation of DNA-protein conjugates. In a concentration-dependent manner, it specifically targets HT-1080 human fibrosarcoma cells, triggering DNA damage. An essential contributor to Cyclophosphamide′s anticancer activity, Phosphoramide Mustard Cyclohexanamine exhibits great promise for cancer research, as it has the potential to induce DNA adduct formation and activate the ovarian DNA repair response in granulosa cells.

Application

Used in the development of chemotherapeutic drugs that are known to treat cancer.

Actions biochimiques/physiologiques

Phosphoramide mustard cyclohexanamine induces cytotoxicity by forming cross-linked DNA adducts that hinder DNA strand separation during replication. This compound destroys rapidly dividing cells and leads to DNA damage. In a study with rat ovarian granulosa cells (SIGCs), it reduced cell viability and increased DNA damage response (DDR) gene expression and protein levels. In animal models, it exhibited significant anticancer activity by inhibiting tumor growth. These findings highlight the potential of Phosphoramide mustard cyclohexanamine in cancer research

Caractéristiques et avantages

  • High quality compound suitable for multiple research applications
  • Compatible with a wide variety of chromatographic and spectrometry techniques

Autres remarques

For additional information on our range of Biochemicals, please complete this form.
This product is intended for research purposes only, and it is not meant for human consumption.

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 3

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable


Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

Désolés, nous n'avons pas de COA pour ce produit disponible en ligne pour le moment.

Si vous avez besoin d'assistance, veuillez contacter Service Clients

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Kendra L Clark et al.
Biology of reproduction, 102(1), 248-260 (2019-08-23)
Ataxia-telangiectasia-mutated (ATM) protein recognizes and repairs DNA double strand breaks through activation of cell cycle checkpoints and DNA repair proteins. Atm gene mutations increase female reproductive cancer risk. Phosphoramide mustard (PM) induces ovarian DNA damage and destroys primordial follicles, and
S A M Gernaat et al.
Scientific reports, 11(1), 2707-2707 (2021-02-03)
Cyclophosphamide (CPA) dosing by body surface area (BSA, m2) has been questioned as a predictor for individual drug exposure. This study investigated phosphoramide mustard-hemoglobin (PAM-Hb, pmol g-1 Hb) as a biomarker of CPA exposure in 135 female breast cancer patients
Julia Delahousse et al.
Journal for immunotherapy of cancer, 8(2) (2020-08-14)
Oxazaphosphorines (cyclophosphamide (CPA), ifosfamide (IFO)) are major alkylating agents of polychemotherapy protocols but limiting their toxicity and increasing their efficacy could be of major interest. Oxazaphosphorines are prodrugs that require an activation by cytochrome P450 (CYP). CPA is mainly metabolized

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique